Immunic, Inc.IMUXNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+4.8%
5Y CAGR+16.2%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+4.8%/yr
vs +30.2%/yr prior
5Y CAGR
+16.2%/yr
Recent deceleration
Acceleration
-25.4pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$81.98M+2.4%
2024$80.05M-3.8%
2023$83.22M+16.8%
2022$71.25M+16.6%
2021$61.12M+58.2%
2020$38.64M+71.6%
2019$22.51M-9.3%
2018$24.82M-36.9%
2017$39.34M+30.9%
2016$30.05M-